Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000–2018

BACKGROUND: Historically, survivors of common lymphoid neoplasms (LNs) had increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML). Despite major treatment advances in the treatment of LNs over the last two decades, a comprehensive evaluation of tMDS/AML trends...

Descripción completa

Detalles Bibliográficos
Autores principales: Morton, Lindsay M., Curtis, Rochelle E., Linet, Martha S., Schonfeld, Sara J., Advani, Pragati G., Dalal, Nicole H., Sasse, Elizabeth C., Dores, Graça M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344829/
https://www.ncbi.nlm.nih.gov/pubmed/37457112
http://dx.doi.org/10.1016/j.eclinm.2023.102060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344829/
https://www.ncbi.nlm.nih.gov/pubmed/37457112
http://dx.doi.org/10.1016/j.eclinm.2023.102060

Ejemplares similares